MEDIUM confidence: 100% data completeness, but the composite (43) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $27M— | $27M-2.8% | $60M+125.7% | $434M+624.1% | $46M-89.4% |
| EPS (dil.) | $-2.65— | $-2.52n/m | $-1.39n/m | $4.23n/m | $-2.05-148.5% |
| Free Cash Flow | -$109M— | -$109Mn/m | -$71Mn/m | $183Mn/m | $56M-69.3% |
| Gross Margin | 100.0% | 100.0%0.0pp | 100.0%0.0pp | 100.0%0.0pp | 97.3%-2.7pp |
| Operating Margin | -460.0% | -494.2%-34.2pp | -156.1%+338.1pp | 58.2%+214.3pp | -343.6%-401.8pp |
| Net Margin | -458.9% | -479.3%-20.3pp | -131.6%+347.7pp | 63.3%+194.9pp | -282.8%-346.2pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Avg target $163 (last qtr, 7 analysts) → $166 (last mo, 6) (+1.9%).
Buy-rated share 92% → 92% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $2.27 | $2.29 | +0.9% |
| May 2026 | $-0.65 | $0.05 | +107.7% |
| Feb 2026 | $-0.53 | $-0.69 | -30.2% |
| Nov 2025 | $-0.59 | $-0.62 | -5.1% |
| Aug 2025 | $-0.53 | $-0.55 | -3.8% |
| May 2025 | $-0.50 | $-0.19 | +62.0% |
| Feb 2025 | $0.06 | $1.98 | +3200.0% |
| Nov 2024 | $-0.59 | $-0.54 | +8.5% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$45.1M over 180 days (0 open-market buys, 16 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 14.2%/yr (revenue basis).
Base free cash flow $56M (avg FY2023–FY2025; latest year $56M) · equity value $9.9B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 43 for PTGX indicates a neutral outlook, driven by a divergence between its long-term and short-term scores, with the latter being 17 points higher. The stock scores high on momentum, exhibiting strong price appreciation of 182% over the past year, but is dragged down by poor growth and value scores, due to a P/E of 126.2 and revenue growth of -89.4%. The stock trades at a premium, with a P/B of 12.0, and exhibits moderate profitability, with an ROE of 12.0%.